Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients
Authors:
- Pierre MeyerPMPierre Meyer
- Cécile NotarnicolaCNCécile Notarnicola
- Albano C. MeliAMAlbano C. Meli
- Stefan MateckiSMStefan Matecki
- Gérald HugonGHGérald Hugon
- Jérémy SalvadorJSJérémy Salvador
- Mirna KhalilMKMirna Khalil
- Léonard FéassonLFLéonard Féasson
- Claude CancesCCClaude Cances
- Jérôme CottalordaJCJérôme Cottalorda
- Isabelle DesguerreIDIsabelle Desguerre
- Jean-Marie CuissetJCJean-Marie Cuisset
Open Access
- 30 November 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (23) , 12985
Abstract
Duchenne muscular dystrophy (DMD) is characterized by progressive muscle wasting following repeated muscle damage and inadequate regeneration. Impaired myogenesis and differentiation play a major role in DMD as well as intracellular calcium (Ca2+) mishandling. Ca2+ release from the sarcoplasmic reticulum is mostly mediated by the type 1 ryanodine receptor (RYR1) that is required for skeletal muscle differentiation in animals. The study objective was to determine whether altered RYR1-mediated Ca2+ release contributes to myogenic differentiation impairment in DMD patients. The comparison of primary cultured myoblasts from six boys with DMD and five healthy controls highlighted delayed myoblast differentiation in DMD. Silencing RYR1 expression using specific si-RNA in a healthy control induced a similar delayed differentiation. In DMD myotubes, resting intracellular Ca2+ concentration was increased, but RYR1-mediated Ca2+ release was not changed compared with control myotubes. Incubation with the RYR-calstabin interaction stabilizer S107 decreased resting Ca2+ concentration in DMD myotubes to control values and improved calstabin1 binding to the RYR1 complex. S107 also improved myogenic differentiation in DMD. Furthermore, intracellular Ca2+ concentration was correlated with endomysial fibrosis, which is the only myopathologic parameter associated with poor motor outcome in patients with DMD. This suggested a potential relationship between RYR1 dysfunction and motor impairment. Our study highlights RYR1-mediated Ca2+ leakage in human DMD myotubes and its key role in myogenic differentiation impairment. RYR1 stabilization may be an interesting adjunctive therapeutic strategy in DMD.Keywords
Funding Information
- Direction Générale de l’Offre de Soins – Institut National de la Santé et de la Recherche Médicale (DGOS-INSERM), France (2012-A00437-36)
This publication has 72 references indexed in Scilit:
- Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stageDevelopment, 2012
- Leaky ryanodine receptors in β-sarcoglycan deficient mice: a potential common defect in muscular dystrophySkeletal Muscle, 2012
- Ryanodine Receptor Oxidation Causes Intracellular Calcium Leak and Muscle Weakness in AgingCell Metabolism, 2011
- Ryanodine receptor leak mediated by caspase-8 activation leads to left ventricular injury after myocardial ischemia-reperfusionProceedings of the National Academy of Sciences, 2011
- Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophyProceedings of the National Academy of Sciences, 2010
- Calcium influx is sufficient to induce muscular dystrophy through a TRPC-dependent mechanismProceedings of the National Academy of Sciences, 2009
- Identification of valid reference genes during the differentiation of human myoblastsBMC Molecular Biology, 2009
- Muscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formationDisease Models & Mechanisms, 2009
- Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscleNature Medicine, 2009
- An Ryr1
I4895T
mutation abolishes Ca 2+ release channel function and delays development in homozygous offspring of a mutant mouse lineProceedings of the National Academy of Sciences, 2007